Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia
- Author
- MIDHA, K. K1 ; HUBBARD, J. W1 ; MARDER, S. R; MARSHALL, B. D
[1] Univ. Saskatchewan, coll. pharmacy medicine, Saskatoon SK, Canada - Source
Journal of psychiatry & neuroscience. = Revue de psychiatrie & de neuroscience. 1994, Vol 19, Num 4, pp 254-264 ; ref : 23 ref
- ISSN
- 1180-4882
- Scientific domain
- Psychology, psychopathology, psychiatry
- Publisher
- Canadian Medical Association, Ottawa, ON
- Publication country
- Canada
- Document type
- Article
- Language
- English
- Keyword (fr)
- Article synthèse Fluphénazine Halopéridol Homme Neuroleptique Pharmacocinétique Posologie Psychose Psychotrope Schizophrénie Voie administration
- Keyword (en)
- Review Human Neuroleptic Pharmacokinetics Posology Psychosis Psychotropic Schizophrenia Route of administration
- Keyword (es)
- Artículo síntesis Hombre Neuroléptico Farmacocinética Posología Psicosis Psicotropo Esquizofrenia Vía administración
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B03 Psycholeptics: tranquillizer, neuroleptic.
- Discipline
- Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
- Origin
- Inist-CNRS
- Database
- FRANCIS ; PASCAL
- INIST identifier
- 4179186
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Journal of psychiatry & neuroscience\";s:9:\"\u0000*\u0000stitle\";s:22:\"J. psychiatry neurosci\";s:7:\"\u0000*\u0000date\";s:4:\"1994\";s:9:\"\u0000*\u0000volume\";s:2:\"19\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"254\";s:8:\"\u0000*\u0000epage\";s:3:\"264\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1180-4882\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MIDHA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"K. K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:13:\"HUBBARD, J. W\";i:1;s:12:\"MARDER, S. R\";i:2;s:14:\"MARSHALL, B. D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:89:\"Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia\";s:8:\"\u0000*\u0000place\";s:10:\"Ottawa, ON\";s:6:\"\u0000*\u0000pub\";s:28:\"Canadian Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Journal of psychiatry & neuroscience\";s:9:\"\u0000*\u0000stitle\";s:22:\"J. psychiatry neurosci\";s:7:\"\u0000*\u0000date\";s:4:\"1994\";s:9:\"\u0000*\u0000volume\";s:2:\"19\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"254\";s:8:\"\u0000*\u0000epage\";s:3:\"264\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1180-4882\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MIDHA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"K. K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:13:\"HUBBARD, J. W\";i:1;s:12:\"MARDER, S. R\";i:2;s:14:\"MARSHALL, B. D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:89:\"Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia\";s:8:\"\u0000*\u0000place\";s:10:\"Ottawa, ON\";s:6:\"\u0000*\u0000pub\";s:28:\"Canadian Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Journal of psychiatry & neuroscience\";s:9:\"\u0000*\u0000stitle\";s:22:\"J. psychiatry neurosci\";s:7:\"\u0000*\u0000date\";s:4:\"1994\";s:9:\"\u0000*\u0000volume\";s:2:\"19\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"254\";s:8:\"\u0000*\u0000epage\";s:3:\"264\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1180-4882\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MIDHA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"K. K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:13:\"HUBBARD, J. W\";i:1;s:12:\"MARDER, S. R\";i:2;s:14:\"MARSHALL, B. D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:89:\"Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia\";s:8:\"\u0000*\u0000place\";s:10:\"Ottawa, ON\";s:6:\"\u0000*\u0000pub\";s:28:\"Canadian Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Journal of psychiatry & neuroscience\";s:9:\"\u0000*\u0000stitle\";s:22:\"J. psychiatry neurosci\";s:7:\"\u0000*\u0000date\";s:4:\"1994\";s:9:\"\u0000*\u0000volume\";s:2:\"19\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"254\";s:8:\"\u0000*\u0000epage\";s:3:\"264\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1180-4882\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MIDHA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"K. K\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:13:\"HUBBARD, J. W\";i:1;s:12:\"MARDER, S. R\";i:2;s:14:\"MARSHALL, B. D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:89:\"Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia\";s:8:\"\u0000*\u0000place\";s:10:\"Ottawa, ON\";s:6:\"\u0000*\u0000pub\";s:28:\"Canadian Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
